State Street’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

State Street’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-438,104	Closed	-$3.56M	–	3661
2013 Q2	$3.56M	Buy	+438,104	New	+$3.24M	﹤0.01%	2656

Other funds holding TSRX

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

State Street's TSRX Position: Q3 2013 in Review

State Street sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 438,104 shares — an estimated $3.56M sold.

State Street first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $3.56M in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

State Street reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
State Street sold 438,104 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $3.56M.
State Street first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
State Street's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $3.56M in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on State Street's 13F filing for Q3 2013, filed 12 Nov 2013.